GLOBUS MEDICAL, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 66.18 USD | -0.12% |
|
+5.61% | +24.54% |
Presentation Operator MessageOperator (Operator)Welcome to Globus Medical's Second Quarter 202...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
Calendar
2024-07-31
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
66.26
USD
Average target price
70.42
USD
Spread / Average Target
+6.27%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +24.54% | 8.95B | |
| -6.49% | 180B | |
| +3.11% | 112B | |
| -3.05% | 68.53B | |
| +5.33% | 51.97B | |
| +5.81% | 44.08B | |
| +5.62% | 42.23B | |
| +23.65% | 32.43B | |
| +16.72% | 26.39B | |
| -3.22% | 24.97B |
- Stock Market
- Equities
- GMED Stock
- News Globus Medical, Inc.
- Transcript : Globus Medical, Inc., Q2 2021 Earnings Call, Aug 04, 2021
